These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 1711448)
21. The safety of amlodipine. Osterloh I Am Heart J; 1989 Nov; 118(5 Pt 2):1114-9; discussion 1119-20. PubMed ID: 2573265 [TBL] [Abstract][Full Text] [Related]
22. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action. Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715 [TBL] [Abstract][Full Text] [Related]
23. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension]. Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044 [TBL] [Abstract][Full Text] [Related]
28. The efficacy of amlodipine in the management of ischaemic heart disease. McGibney D Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871 [TBL] [Abstract][Full Text] [Related]
30. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. Croom KF; Wellington K Drugs; 2006; 66(4):497-528. PubMed ID: 16597165 [TBL] [Abstract][Full Text] [Related]
31. [Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside]. Höfling B; Häringer E; Herrmann W; Pieske H; Pieske R; Philippi M Fortschr Med; 1991 May; 109(15):327-30. PubMed ID: 1830287 [TBL] [Abstract][Full Text] [Related]
32. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension]. Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807 [TBL] [Abstract][Full Text] [Related]
36. Amlodipine in hypertension: an overview of the clinical dossier. Julius S J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S27-33. PubMed ID: 2467123 [TBL] [Abstract][Full Text] [Related]
37. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders. Murdoch D; Brogden RN Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708 [TBL] [Abstract][Full Text] [Related]
38. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine. Elliott HL; Meredith PA Postgrad Med J; 1991; 67 Suppl 3():S20-3. PubMed ID: 1836870 [TBL] [Abstract][Full Text] [Related]
39. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]